| __timestamp | ImmunityBio, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 1802274 |
| Thursday, January 1, 2015 | 226206000 | 2512761 |
| Friday, January 1, 2016 | 94391000 | 2894488 |
| Sunday, January 1, 2017 | 53821000 | 8096274 |
| Monday, January 1, 2018 | 35463000 | 7985229 |
| Tuesday, January 1, 2019 | 46456000 | 8994597 |
| Wednesday, January 1, 2020 | 71318000 | 29772000 |
| Friday, January 1, 2021 | 135256000 | 33907000 |
| Saturday, January 1, 2022 | 102708000 | 26579000 |
| Sunday, January 1, 2023 | 129620000 | 49868547 |
In pursuit of knowledge
In the ever-evolving biotech industry, understanding financial trends is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and ImmunityBio, Inc. over the past decade. ImmunityBio, Inc. has shown a remarkable increase in SG&A spending, peaking in 2015 with a staggering 2,262% rise from the previous year. Meanwhile, Verona Pharma plc has maintained a more conservative growth, with its highest expenditure in 2023, marking a 177% increase from 2022. This divergence highlights ImmunityBio's aggressive expansion strategy compared to Verona Pharma's steady approach. Such insights are invaluable for investors and stakeholders aiming to gauge the financial health and strategic direction of these companies. As the biotech sector continues to grow, monitoring these spending patterns will be key to predicting future market movements.
Selling, General, and Administrative Costs: Johnson & Johnson vs Verona Pharma plc
SG&A Efficiency Analysis: Comparing Novartis AG and Verona Pharma plc
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.